Vivasure Medical closes $23m tranche
Vivasure Medical, a provider of absorbable technology for percutaneous vessel closure, has closed the first $23 million tranche as part of its Series D funding that could reach up to $54 million.
Vivasure Medical, a provider of absorbable technology for percutaneous vessel closure, has closed the first $23 million tranche as part of its Series D funding that could reach up to $54 million.
Copyright PEI Media
Not for publication, email or dissemination